PKU HealthCare Corp.,Ltd. (SHE:000788)
China · Delayed Price · Currency is CNY 6.31
+0.05 (0.80%)
Feb 4, 2026, 3:04 PM CST
PKU HealthCare Corp.,Ltd. Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Operating Revenue | 1,751 | 2,055 | 2,189 | 2,072 | 2,231 | 1,968 |
Other Revenue | 5.43 | 5.43 | 4.68 | 4.93 | 6.19 | 9.28 |
| 1,757 | 2,060 | 2,194 | 2,077 | 2,237 | 1,977 | |
Revenue Growth (YoY) | -15.24% | -6.10% | 5.61% | -7.13% | 13.12% | -21.19% |
Cost of Revenue | 1,302 | 1,512 | 1,482 | 1,305 | 1,328 | 1,093 |
Gross Profit | 455.33 | 548.39 | 711.92 | 772.12 | 908.96 | 884.44 |
Selling, General & Admin | 227.99 | 311.94 | 577.18 | 653.29 | 769.44 | 772.65 |
Research & Development | 32.07 | 27.04 | 27.8 | 14.74 | 14.08 | 8.71 |
Other Operating Expenses | 8.01 | 9.31 | 11.09 | 11.45 | 12.26 | 10.1 |
Operating Expenses | 258.02 | 336.76 | 613.71 | 678.28 | 808.08 | 808.08 |
Operating Income | 197.3 | 211.62 | 98.21 | 93.84 | 100.88 | 76.36 |
Interest Expense | -3.68 | -4.17 | -6.98 | -18.48 | -22.78 | -16.6 |
Interest & Investment Income | 8.56 | 5.03 | 6.37 | 6.96 | 6.75 | 7.74 |
Currency Exchange Gain (Loss) | -0 | -0 | -0 | -0.01 | 0 | 0.01 |
Other Non Operating Income (Expenses) | 3.07 | -0.2 | -0.18 | -0.17 | -0.17 | 1.94 |
EBT Excluding Unusual Items | 205.24 | 212.28 | 97.42 | 82.15 | 84.69 | 69.44 |
Gain (Loss) on Sale of Investments | 6.14 | -0.24 | -1.16 | -1.54 | - | -6.05 |
Gain (Loss) on Sale of Assets | -0.05 | 0.19 | 0.01 | 1.12 | - | - |
Asset Writedown | -37.92 | -42.16 | -19.93 | -12.72 | -25.76 | -8.86 |
Legal Settlements | - | - | -0.53 | -5.72 | -2.68 | -1.95 |
Other Unusual Items | 2.28 | 2.28 | -1.52 | 7.3 | 5.66 | - |
Pretax Income | 175.7 | 172.35 | 74.29 | 70.59 | 61.91 | 52.58 |
Income Tax Expense | 32.04 | 34.36 | 29.94 | 15.17 | 18.76 | 13.4 |
Earnings From Continuing Operations | 143.66 | 137.99 | 44.35 | 55.42 | 43.15 | 39.18 |
Minority Interest in Earnings | -0.05 | - | 0 | 0.19 | -0 | 0.01 |
Net Income | 143.61 | 137.99 | 44.36 | 55.61 | 43.14 | 39.18 |
Net Income to Common | 143.61 | 137.99 | 44.36 | 55.61 | 43.14 | 39.18 |
Net Income Growth | 11.69% | 211.10% | -20.23% | 28.88% | 10.11% | -21.93% |
Shares Outstanding (Basic) | 596 | 596 | 596 | 596 | 596 | 560 |
Shares Outstanding (Diluted) | 596 | 596 | 596 | 596 | 596 | 560 |
Shares Change (YoY) | -0.04% | -0.03% | 0.03% | 0.01% | 6.46% | -6.09% |
EPS (Basic) | 0.24 | 0.23 | 0.07 | 0.09 | 0.07 | 0.07 |
EPS (Diluted) | 0.24 | 0.23 | 0.07 | 0.09 | 0.07 | 0.07 |
EPS Growth | 11.72% | 211.16% | -20.26% | 28.87% | 3.43% | -16.86% |
Free Cash Flow | 364.27 | 308.38 | 58.65 | 243.57 | 13.74 | -126.23 |
Free Cash Flow Per Share | 0.61 | 0.52 | 0.10 | 0.41 | 0.02 | -0.23 |
Dividend Per Share | 0.228 | 0.080 | 0.026 | - | 0.023 | - |
Dividend Growth | 200.00% | 207.69% | - | - | - | - |
Gross Margin | 25.92% | 26.62% | 32.45% | 37.17% | 40.64% | 44.73% |
Operating Margin | 11.23% | 10.27% | 4.48% | 4.52% | 4.51% | 3.86% |
Profit Margin | 8.17% | 6.70% | 2.02% | 2.68% | 1.93% | 1.98% |
Free Cash Flow Margin | 20.73% | 14.97% | 2.67% | 11.72% | 0.61% | -6.38% |
EBITDA | 227.7 | 241.39 | 127.15 | 119.65 | 121.87 | 94.99 |
EBITDA Margin | 12.96% | 11.72% | 5.80% | 5.76% | 5.45% | 4.80% |
D&A For EBITDA | 30.39 | 29.77 | 28.93 | 25.81 | 20.99 | 18.63 |
EBIT | 197.3 | 211.62 | 98.21 | 93.84 | 100.88 | 76.36 |
EBIT Margin | 11.23% | 10.27% | 4.48% | 4.52% | 4.51% | 3.86% |
Effective Tax Rate | 18.23% | 19.94% | 40.30% | 21.49% | 30.30% | 25.49% |
Revenue as Reported | 1,757 | 2,060 | 2,194 | 2,077 | 2,237 | 1,977 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.